Mignini Irene, Ainora Maria Elena, Di Francesco Silvino, Galasso Linda, Gasbarrini Antonio, Zocco Maria Assunta
CEMAD Digestive Diseases Center, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli, 8, 00168 Rome, Italy.
Cancers (Basel). 2023 Jun 15;15(12):3200. doi: 10.3390/cancers15123200.
Colo-rectal cancer (CRC) is undoubtedly one of the most severe complications of inflammatory bowel diseases (IBD). While sporadic CRC develops from a typical adenoma-carcinoma sequence, IBD-related CRC follows different and less understood pathways and its pathophysiological mechanisms were not completely elucidated. In contrast to chronic inflammation, which is nowadays a well-recognised drive towards neoplastic transformation in IBD, only recently was gut microbiota demonstrated to interfere with both inflammation processes and immune-mediated anticancer surveillance. Moreover, the role of microbiota appears particularly complex and intriguing when also considering its multifaceted interactions with multiple environmental stimuli, notably chronic pathologies such as diabetes and obesity, lifestyle (diet, smoking) and vitamin intake. In this review, we presented a comprehensive overview on current evidence of the influence of gut microbiota on IBD-related CRC, in particular its mutual interconnections with the environment.
结直肠癌(CRC)无疑是炎症性肠病(IBD)最严重的并发症之一。散发性结直肠癌由典型的腺瘤-癌序列发展而来,而IBD相关的结直肠癌则遵循不同且尚不太清楚的途径,其病理生理机制尚未完全阐明。与如今已被充分认识到的、在IBD中驱动肿瘤转化的慢性炎症不同,肠道微生物群直到最近才被证明会干扰炎症过程和免疫介导的抗癌监测。此外,当考虑到微生物群与多种环境刺激(尤其是糖尿病和肥胖等慢性疾病、生活方式(饮食、吸烟)和维生素摄入)的多方面相互作用时,微生物群的作用显得尤为复杂和引人入胜。在本综述中,我们全面概述了肠道微生物群对IBD相关结直肠癌影响的当前证据,特别是其与环境的相互联系。